Association between angiotensin-converting enzyme gene polymorphism and diabetic retinopathy in the Chinese population

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 13, Issue 2, 2012, Pages 289-295

  Lu, Yan ^a   Ge, Yirui ^a   Hu, Qinrui ^a   Shi, Yuhua ^a   Xue, Chunyan ^a   Shi, Yao ^a   Chen, Suihua ^a   Huang, Zhenping ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Chinese; diabetic retinopathy; meta analysis; polymorphism; the angiotensin converting enzyme gene

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CHINESE; DIABETIC RETINOPATHY; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INDEL MUTATION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DIABETIC RETINOPATHY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; MODELS, GENETIC; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PUBLICATION BIAS;

EID: 84861915626     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320311432187     Document Type: Article

References (31)

1. Resnikoff S. Global data on visual impairment in the year 2002. Bulletin of the World Health Organization. 2004 ; 82: 844-851 (Pubitemid 39573742)
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001 ; 414: 813-820 (Pubitemid 34000785)
3. Abhary S, Hewitt AW, Burdon KP, Craig JE. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes. 2009 ; 58: 2137-2147
4. Hallman DM, Huber JC, Gonzalez VH, Klein BE, Klein R, Hanis CL. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care. 2005 ; 28: 1163-1168 (Pubitemid 40616629)
5. Hogeboom van Buggenum IM, Polak BC, Reichert-Thoen JW, de Vries-Knoppert WA, van Hinsbergh VW, Tangelder GJ. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. Diabetologia. 2002 ; 45: 203-209 (Pubitemid 34208382)
6. Van Dyk DJ, Erman A, Erman T, Chen-Gal B, Sulkes J, Boner G. Increased serum angiotensin converting enzyme activity in type I insulin-dependent diabetes mellitus: its relation to metabolic control and diabetic complications. Eur J Clin Invest. 1994 ; 24: 463-467 (Pubitemid 24232619)
7. Zhou JB, Yang JK. Angiotensin-converting enzyme gene polymorphism is associated with proliferative diabetic retinopathy: a meta-analysis. Acta Diabetol. 2010 ; 47: 187-193
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 ; 7: 177-188 (Pubitemid 17189972)
9. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 ; 22: 719-748
10. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994 ; 50: 1088-1101
11. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 ; 315: 629-634 (Pubitemid 27387172)
12. Hu W, Wang L, Liu CX. Association between ACE gene polymorphism and diabetic retinopathy. Journal of Capital University of Medical Sciences. 1998 ; 19: 41-44
13. Liao L, Lei MX, Chen HL, Han XY, Fan C. Studies on ACE gene insertion/deletion polymorphism, serum ACE activity, and diabetic retinopathy in type 2 diabetic patients. Bull of Hunan Med Univ. 1999 ; 24: 33-36
14. Liu J, Jing HE, Zhang W, et al. Association between ACE gene polymorphism and diabetic retinopathy in Chinese population. Chin J Ocul Fundus Dis. 1999 ; 15: 37-38
15. Wang DW, Ye Z, Zhang X, et al. Association between ACE gene polymorphism and diabetic retinopathy in type 2 diabetic patients. Chinese Journal of Diabetes. 1999 ; 7: 299-300
16. Xiang KS, Zheng TS, Sun DQ, Weng Q, Xu J, Li J. The association of three genes of the renin-angiotensin system with diabetic retinopathy. Chinese Journal of Diabetes. 1999 ; 7: 5-8
17. Zhang YL, Li Y, Wang Y, et al. Relationship between angiotensin- converting enzyme gene polymorphism and diabetic retinopathy in NIDDM patients of Hebei Province. Journal of Hebei Medical University. 1999 ; 20: 338-340
18. Yang XJ, Li X, Liu JY, Chen SJ, Luo HW. Association between ACE gene polymorphism and diabetic microangiopathy. Chinese Journal of Practical Internal Medicine. 2000 ; 20: 487-488
19. Xiang GD, Le L, Xia BS, Jiang W, Li XD, Xiao WF. Association between ACE gene polymorphism and large or micro vascular disease in NIDDM patients. Chinese Journal of Medical Genetics. 2001 ; 18: 235-236
20. Xu L, Wang DQ, Zhang XY, Ren JM. Association of Angiotensin II1 receptor and angiotensin I-converting enzyme gene polymorphisms with and diabetic retinopathy in type 2 diabetic patients. Chin J Ocul Fundus Dis. 2001 ; 17: 190-191
21. Liao YH, Xian S, Luo ZJ, et al. Relationship between the polymorphism of angiotensin converting enzyme gene and vascular complications in type 2 diabetes in Guangxi region. Chinese Journal of Practical Internal Medicine. 2002 ; 22: 270-272
22. Xu L, Deng ZX, Wu YL, He RH, Tang JY. The relationship of angiotensin-converting enzyme(ACE) gene polymorphism and serum ACE levels with retinopathy in patients with type 2 diabetes mellitus. Chinese Journal of Diabetes. 2003 ; 11: 344-347
23. Xue YM, Guan MP, Shen J, Zhou L, Gao F. Analysis of risk factors for type 2 diabetic retinopathy. Chinese Journal of Practice Medicine. 2003 ; 2: 682-683
24. Liao L, Lei MX, Chen HL, Guo LJ, Han XY. Angiotensin converting enzyme gene polymorphism and type 2 diabetic retinopathy. J Cent South Univ (Med Sci). 2004 ; 29: 410-413
25. Wu SS, Guo QM, Liu GL, et al. The relationship of angiotensin I-converting enzyme gene polymorphism with diabetic retinopathy and diabetes myocardial infarction. Chin J Med genet. 2004 ; 21: 283-285
26. Cheng JL, Shen MY, Wang JS, et al. Correlation of gene polymorphism of angiotensin converting enzyme and type 2 diabetic retinopathy. Clinical Medicine of China. 2005 ; 21: 608-610
27. Liang S, Bian CJ, Huan HJ, Chen H. Detection of angiotensin converting enzyme gene insertion/deletion polymorphism and its relationship with diabetic retinopathy. Chin Ophthal Res. 2006 ; 24: 654-656 (Pubitemid 46051531)
28. Thaler RH The Winner's Curse: Paradoxes and Anomalies of Economic Life. Princeton, NJ: Princeton University Press ; 1999 :
29. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/ deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 ; 86: 1343-1346 (Pubitemid 20370444)
30. Globocnik-Petrovic M, Hawlina M, Peterlin B, Petrovic D. Insertion/deletion plasminogen activator inhibitor 1 and insertion/deletion angiotensin-converting enzyme gene polymorphisms in diabetic retinopathy in type 2 diabetes. Ophthalmologica. 2003 ; 217: 219-224 (Pubitemid 36359537)
31. Jeganathan VS. The therapeutic implications of renin- angiotensin system blockade in diabetic retinopathy. Curr Pharm Biotechnol. 2011 ; 12: 392-395